Provided by Tiger Trade Technology Pte. Ltd.

Hims & Hers Health Inc.

22.94
-3.0600-11.77%
Pre-market: 22.05-0.8900-3.88%05:06 EST
Volume:50.15M
Turnover:1.17B
Market Cap:5.35B
PE:-36.82
High:25.67
Open:25.25
Low:22.73
Close:26.00
52wk High:41.28
52wk Low:13.74
Shares:233.31M
Float Shares:213.68M
Volume Ratio:4.14
T/O Rate:23.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6230
EPS(LYR):0.5123
ROE:-32.03%
ROA:-2.21%
PB:16.52
PE(LYR):44.78

Loading ...

Hims & Hers Appoints Andrew Huberman to Board of Directors

Reuters
·
12 hours ago

Hims & Hers Health Q3 Revenue USD 890 Million Vs. IBES Estimate USD 892.9 Million

Reuters
·
13 hours ago

Hims & Hers Health Outlook FY Revenue USD 3,130-3,150 Million

THOMSON REUTERS
·
13 hours ago

Hims & Hers Stock is Falling Ahead of Earnings. What to Expect.

Dow Jones
·
13 hours ago

Hims & Hers Stock Plunges Before Earnings: What to Watch

Benzinga Earnings
·
15 hours ago

Movement Alert|Hims & Hers Health Inc. Falls 5.65% in Regular Trading, Recent Partnership Tailwind Fails to Offset Ongoing Regulatory Overhang

Market Focus
·
Yesterday

Hims Partnership Could Be A Big Deal For Eli Lilly (LLY)

Simply Wall St.
·
Nov 08

Lilly’s Drugs, Hims’ Customers: Who Gets the Bigger Payoff?

Bellwether Stocks Movement
·
Nov 07

Hims Stock In Focus As Benefits Program Expands Before Earnings

Simply Wall St.
·
Nov 07

Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (HIMS), Humana (HUM) and Vericel (VCEL)

TIPRANKS
·
Nov 07

Hims & Hers Struck a GLP-1 Deal with Lilly. Its Stock is Rallying.

Dow Jones
·
Nov 07

Movement Alert|Hims & Hers Health Inc. Intraday Rise 6.59% in Regular Trading, Eli Lilly partnership expands access to weight-loss drugs

Market Focus
·
Nov 06

Sector Update: Healthcare Stocks Decline Premarket Friday

MT Newswires Live
·
Nov 06

Why Hims & Hers Health Stock was in Dire Need of This Eli Lilly Agreement

Dow Jones
·
Nov 06

Hims & Hers Rises as Lilly Expands Weight-Loss Drug Access Through Platform

Reuters
·
Nov 06

Hims & Hers Shares up 7.5% Premarket as Lilly to Sell Its Obesity Drugs on Co's Platform

THOMSON REUTERS
·
Nov 06

Movement Alert|Hims & Hers Health Inc. Rises 6.36% in Pre-Market Trading, Earnings Expectations Help Offset Litigation Overhang

Market Focus
·
Nov 06

Eli Lilly: Hims & Hers Has Committed not to Offer Access to Compounded Copies of Lilly’s Glp-1S in Future

THOMSON REUTERS
·
Nov 06

Eli Lilly: Co, Hims & Hers Health Announced Agreement to Help Expand Access to Zepbound (Tirzepatide) & Foundayo (Orforglipron)

THOMSON REUTERS
·
Nov 06

Lilly to Sell Obesity Drugs Directly on Hims & Hers Site

Reuters
·
Nov 06